1
|
Nättinen J, Aapola U, Nukareddy P, Uusitalo H. Clinical Tear Fluid Proteomics—A Novel Tool in Glaucoma Research. Int J Mol Sci 2022; 23:ijms23158136. [PMID: 35897711 PMCID: PMC9331117 DOI: 10.3390/ijms23158136] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2022] [Revised: 07/18/2022] [Accepted: 07/21/2022] [Indexed: 02/05/2023] Open
Abstract
Tear fluid forms the outermost layer of the ocular surface and its characteristics and composition have been connected to various ocular surface diseases. As tear proteomics enables the non-invasive investigation of protein levels in the tear fluid, it has become an increasingly popular approach in ocular surface and systemic disease studies. Glaucoma, which is a set of multifactorial diseases affecting mainly the optic nerve and retinal ganglion cells, has also been studied using tear proteomics. In this condition, the complete set of pathophysiological changes occurring in the eye is not yet fully understood, and biomarkers for early diagnosis and accurate treatment selection are needed. More in-depth analyses of glaucoma tear proteomics have started to emerge only more recently with the implementation of LC-MS/MS and other modern technologies. The aim of this review was to examine the published data of the tear protein changes occurring during glaucoma, its topical treatment, and surgical interventions.
Collapse
Affiliation(s)
- Janika Nättinen
- Eye and Vision Research, Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland; (U.A.); (P.N.); (H.U.)
- Tays Eye Centre, Tampere University Hospital, 33520 Tampere, Finland
- Correspondence:
| | - Ulla Aapola
- Eye and Vision Research, Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland; (U.A.); (P.N.); (H.U.)
- Tays Eye Centre, Tampere University Hospital, 33520 Tampere, Finland
| | - Praveena Nukareddy
- Eye and Vision Research, Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland; (U.A.); (P.N.); (H.U.)
| | - Hannu Uusitalo
- Eye and Vision Research, Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland; (U.A.); (P.N.); (H.U.)
- Tays Eye Centre, Tampere University Hospital, 33520 Tampere, Finland
| |
Collapse
|
2
|
Nandi SK, Singh D, Upadhay J, Gupta N, Dhiman N, Mittal SK, Mahindroo N. Identification of tear-based protein and non-protein biomarkers: Its application in diagnosis of human diseases using biosensors. Int J Biol Macromol 2021; 193:838-846. [PMID: 34728300 DOI: 10.1016/j.ijbiomac.2021.10.198] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2021] [Revised: 09/30/2021] [Accepted: 10/26/2021] [Indexed: 12/27/2022]
Abstract
Discovery of robust, selective and specific biomarkers are important for early diagnosis and monitor progression of human diseases. Eye being a common target for several human diseases, vision impediment and complications are often associated with systemic and ocular diseases. Tears are bodily fluids that are closest to eye and are rich in protein content and other metabolites. As a biomarker repository, it advantages over other bodily fluids due to the ability to collect it non-invasively. In this review, we highlight some recent advancements in identification of tear-based protein biomarkers like lacryglobin and cystatin SA for cancer; interleukin-6 and immunoglobulin-A antibody for COVID-19; tau, amyloid-β-42 and lysozyme-C for Alzheimer's disease; peroxiredoxin-6 and α-synuclein for Parkinson's disease; kallikrein, angiotensin converting enzyme and lipocalin-1 for glaucoma; lactotransferrin and lipophilin-A for diabetic retinopathy and zinc-alpha-2 glycoprotein-1, prolactin and calcium binding protein-A4 for eye thyroid disease. We also discussed identification of tear based non-protein biomarkers like lysophospholipids and acetylcarnitine for glaucoma, 8-hydroxy-2'-deoxyquanosine and malondialdehyde for thyroid eye disease. We elucidate technological advancement in developing tear-based biosensors for diagnosis and monitoring diseases such as diabetes, diabetic retinopathy and Alzheimer's disease. Altogether, the study of tears as potential biomarkers for early diagnosis of human diseases is promising.
Collapse
Affiliation(s)
- Sandip K Nandi
- School of Health Sciences, University of Petroleum and Energy Studies, Dehradun, Uttarakhand 248007, India.
| | - Deepanmol Singh
- School of Health Sciences, University of Petroleum and Energy Studies, Dehradun, Uttarakhand 248007, India
| | - Jyoti Upadhay
- School of Health Sciences, University of Petroleum and Energy Studies, Dehradun, Uttarakhand 248007, India
| | - Neeti Gupta
- Department of Ophthalmology, All India Institute of Medical Sciences, Rishikesh 249203, India
| | - Nayan Dhiman
- School of Health Sciences, University of Petroleum and Energy Studies, Dehradun, Uttarakhand 248007, India
| | - Sanjeev Kumar Mittal
- Department of Ophthalmology, All India Institute of Medical Sciences, Rishikesh 249203, India
| | - Neeraj Mahindroo
- School of Health Sciences, University of Petroleum and Energy Studies, Dehradun, Uttarakhand 248007, India.
| |
Collapse
|
3
|
Aluru SV, Shweta A, Bhaskar S, Geetha K, Sivakumar RM, Utpal T, Padmanabhan P, Angayarkanni N. Tear Fluid Protein Changes in Dry Eye Syndrome Associated with Rheumatoid Arthritis: A Proteomic Approach. Ocul Surf 2017; 15:112-129. [DOI: 10.1016/j.jtos.2016.09.005] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2016] [Revised: 08/31/2016] [Accepted: 09/06/2016] [Indexed: 11/26/2022]
|
4
|
Aluru SV, Agarwal S, Srinivasan B, Iyer GK, Rajappa SM, Tatu U, Padmanabhan P, Subramanian N, Narayanasamy A. Lacrimal proline rich 4 (LPRR4) protein in the tear fluid is a potential biomarker of dry eye syndrome. PLoS One 2012; 7:e51979. [PMID: 23272196 PMCID: PMC3525644 DOI: 10.1371/journal.pone.0051979] [Citation(s) in RCA: 48] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2012] [Accepted: 11/07/2012] [Indexed: 12/02/2022] Open
Abstract
Dry eye syndrome (DES) is a complex, multifactorial, immune-associated disorder of the tear and ocular surface. DES with a high prevalence world over needs identification of potential biomarkers so as to understand not only the disease mechanism but also to identify drug targets. In this study we looked for differentially expressed proteins in tear samples of DES to arrive at characteristic biomarkers. As part of a prospective case-control study, tear specimen were collected using Schirmer strips from 129 dry eye cases and 73 age matched controls. 2D electrophoresis (2DE) and Differential gel electrophoresis (DIGE) was done to identify differentially expressed proteins. One of the differentially expressed protein in DES is lacrimal proline rich 4 protein (LPRR4). LPRR4 protein expression was quantified by enzyme immune sorbent assay (ELISA). LPRR4 was down regulated significantly in all types of dry eye cases, correlating with the disease severity as measured by clinical investigations. Further characterization of the protein is required to assess its therapeutic potential in DES.
Collapse
Affiliation(s)
- Saijyothi Venkata Aluru
- Biochemistry and Cell Biology Department, Vision Research Foundation, Sankara Nethralaya, Chennai, Tamilnadu, India
| | - Shweta Agarwal
- Ocular Surface Clinic, Medical Research Foundation, Sankara Nethralaya, Chennai, Tamilnadu, India
| | - Bhaskar Srinivasan
- Ocular Surface Clinic, Medical Research Foundation, Sankara Nethralaya, Chennai, Tamilnadu, India
| | - Geetha Krishnan Iyer
- Ocular Surface Clinic, Medical Research Foundation, Sankara Nethralaya, Chennai, Tamilnadu, India
| | | | - Utpal Tatu
- Biochemistry Department, Indian Institute of Science (IISc.), Bangalore, Karnataka, India
| | - Prema Padmanabhan
- Ocular Surface Clinic, Medical Research Foundation, Sankara Nethralaya, Chennai, Tamilnadu, India
| | - Nirmala Subramanian
- Oculoplasty Department, Medical Research Foundation, Sankara Nethralaya, Chennai, Tamilnadu, India
| | - Angayarkanni Narayanasamy
- Biochemistry and Cell Biology Department, Vision Research Foundation, Sankara Nethralaya, Chennai, Tamilnadu, India
- * E-mail:
| |
Collapse
|
5
|
Saijyothi AV, Angayarkanni N, Syama C, Utpal T, Shweta A, Bhaskar S, Geetha IK, Vinay PS, Thennarasu M, Sivakumar RM, Prema P. Two dimensional electrophoretic analysis of human tears: collection method in dry eye syndrome. Electrophoresis 2011; 31:3420-7. [PMID: 20882555 DOI: 10.1002/elps.201000271] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Tear proteomics, by 2-DE, can give a fingerprint of the protein profile, which is well suited in clinical proteomics for biomarker identification and in diagnostics. The mode of tear collection can influence the representation of the proteins in the tear and therefore it is important to use the appropriate method. In this study, capillary and Schirmer mode of tear collection was done in the healthy controls and the Schirmer method was validated in dry eye syndrome conditions. 2-D PAGE of normal and dry eye tear was performed using pH 3-10 linear IPG strips followed by 13% SDS-PAGE. The spot intensity was analyzed by the PD quest software. The two methods were compared using Bland-Altman statistical tool. The 2-D map of capillary and Schirmer tear showed 147 ± 8 spots and 145 ± 7 spots respectively. Both the collection methods were in agreement with each other and were comparable. Dry eye tear protein showed differential expression of proteins as observed in 25-35 kDa region. One of the significantly reduced protein was identified as proline-rich 4 protein. Schirmer method of tear collection is reliable in patients with dry eye, which can display the differential protein expression and help in biomarker identification.
Collapse
Affiliation(s)
- Aluru Venkata Saijyothi
- Biochemistry and Cell Biology Department, Vision Research Foundation, Sankara Nethralaya, Chennai, India
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
|
7
|
Proteomics as a research tool in clinical and experimental ophthalmology. Proteomics Clin Appl 2008; 2:762-75. [DOI: 10.1002/prca.200780094] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
|
8
|
Grus FH, Joachim SC, Pfeiffer N. Proteomics in ocular fluids. Proteomics Clin Appl 2007; 1:876-88. [DOI: 10.1002/prca.200700105] [Citation(s) in RCA: 61] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2007] [Indexed: 12/14/2022]
|
9
|
Roedl JB, Bleich S, Reulbach U, Rejdak R, Kornhuber J, Kruse FE, Schlötzer-Schrehardt U, Jünemann AG. Homocysteine in tear fluid of patients with pseudoexfoliation glaucoma. J Glaucoma 2007; 16:234-9. [PMID: 17473737 DOI: 10.1097/ijg.0b013e31802d6942] [Citation(s) in RCA: 50] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
PURPOSE To evaluate homocysteine (Hcy) concentrations in tear fluid and plasma and their association with B-vitamin levels in patients with pseudoexfoliation glaucoma (PEXG). PATIENTS AND METHODS Reflex tear and blood samples were obtained in 30 patients with PEXG and 30 controls. Hcy levels were determined by high-performance liquid chromatography. RESULTS Hcy was detected in all tear fluid samples of patients with PEXG and controls. Statistical analysis with t tests showed that patients with PEXG had significantly higher Hcy levels both in tear fluid (237+/-133 nmol/L vs. 128+/-54 nmol/L; P<0.001) and in plasma (14.51+/-4.43 micromol/L vs. 10.22+/-2.77 micromol/L; P<0.001) than control subjects. Hcy in tear fluid correlated significantly with Hcy in plasma (r=0.438, P=0.015) and with serum B12 levels (r=-0.424, P=0.019) in patients with PEXG, but not in controls. CONCLUSIONS The study suggests increased Hcy levels in tear fluid and plasma of patients with PEXG. Further investigations are needed to evaluate the possible clinical role of Hcy in ocular surface and systemic disorders associated with PEXG.
Collapse
Affiliation(s)
- Johannes B Roedl
- Department of Ophthalmology and University Eye Hospital, Germany.
| | | | | | | | | | | | | | | |
Collapse
|